Launching Clinical Trials In India? Beware Of Long Delays And New Mandates
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Inordinate delays in the approval process for clinical trials may be dissuading sponsors and CROs from considering India as part of their upcoming global programs